Moaid 6mg Tablet, a prescription-only medicine, is a corticosteroid-based product containing 6mg of Deflazacort as the active ingredient. This medication is indicated for the treatment of various inflammatory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD). Moaid 6mg Tablet works by suppressing the body's natural response to inflammation, thereby reducing the production of chemical mediators that contribute to the inflammatory process. It is available in tablet form, with each unit dose containing the fixed dose of 6mg Deflazacort. The recommended dose and duration of treatment are determined by the healthcare provider, based on the patient's specific condition, response to therapy, and potential for adverse effects. As with all corticosteroids, Moaid 6mg Tablet should be used with caution in patients with a history of glaucoma, cataracts, or diabetes, as it may exacerbate these conditions. Additionally, patients should be monitored for signs of adrenal insufficiency, osteoporosis, and behavioral changes, such as mood swings, during treatment.